New TREMFYA® (guselkumab) Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2b QUASAR Induction Study 1 in adults with...

Related Keywords

Japan ,United States ,Spring House ,British Columbia ,Canada ,Canadian ,Craig Stoltz ,Burrillb Crohn ,Brucee Sands ,Jan Wehkamp ,American College Of Gastroenterology Annual Meeting ,Crohn Colitis Foundation ,Janssen Research Development ,Janssen Pharmaceutical Companies ,Janssen Pharmaceutical Companies Of Johnson ,American College Of Gastroenterology ,Japan Pharmaceuticals ,None Of The Janssen Pharmaceutical Companies ,National Institutes Of Health ,Exchange Commission ,Icahn School Of Medicine At Mount Sinai ,Companies Of Johnson ,European Medicines Agency ,Devices Agency ,Canadian Agency For Drugs Technologies In Health ,Johnson ,Crohn Colitis Foundation Of America ,Gastroenterology Annual Meeting ,Annual Scientific Meeting ,Scientific Meeting ,Mount Sinai Hospital ,Icahn School ,Vice President ,Gastroenterology Disease Area Leader ,Janssen Research ,Induction Study ,Prescribing Information ,Medication Guidefor ,Pharmaceutical Companies ,Infectious Diseases ,Private Securities Litigation Reform Act ,Annual Report ,Note Regarding Forward Looking ,Quarterly Reports ,Patients With Moderately ,Severely Active Ulcerative Colitis ,Participants With Moderately ,Accessed September ,Guselkumab Induction Therapy ,Results Through Week ,Multicenter Protocol ,Severely Active Ulcerative ,Modified Permutations ,Mayo Score ,Characterizing Clinical ,Patient Reported Outcomes ,Ulcerative Colitis ,Colitis Foundation ,Facts About Inflammatory Bowel ,Term Efficacy ,Monoclonal Antibody Specific ,Through Two Years ,Results From ,Placebo Controlled Study Conducted ,Biologic Naive Patients With Active Psoriatic ,Canadian Agency ,Medical Devices ,Tremfya Report ,Janssen Pharmaceutical Companies Of Johnson Amp ,